Natural history of benign prostate hyperplasia

Chinese Medical Journal

Volumn 119, Issue 24, 2006, Pages 2085-2089

  Wu, Shi Liang ^a   Li, Ning Chen ^a   Xiao, Yun Xiang ^a   Jin, Jie ^a   Qiu, Shao Peng ^b   Ye, Zhang Qun ^c   Kong, Chui Ze ^d   Sun, Guang ^e   Na, Yan Qun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Benign prostate hyperplasia; Epidemiology; Natural history

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ANALYSIS OF VARIANCE; ANTIGEN DETECTION; ARTICLE; CHI SQUARE TEST; CHINA; DISEASE COURSE; ECHOGRAPHY; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL URINE; STUDENT T TEST; UROFLOWMETRY; WATCHFUL WAITING;

EID: 33845897353     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200612020-00010     Document Type: Article

References (19)

1. Zheng H, Yu PL, Gao FK, Yang Z, Gu MM. A cross-sectional study of common diseases among the elderly in 6 cities of China. Chin J Geriatr (Chin) 2000; 19: 215-218.
2. Desgrandchamps F. Who will benefit from combination therapy? The role of 5 alpha reductase inhibitors and alpha blockade: a reflection from MTOPS. Curr Opin Urol 2004; 14: 17-20.
3. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de La Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004; 46: 547-554.
4. O'Leary MP. Tamsulosin: current clinical experience. Urology 2001; 58: 42-48.
5. Roehrborn CG, McCoonnell J. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik ED, Vaughan JR, eds. Campbell's Urology. Philadelphia: W.B. Saunders; 2002: 1297-1330.
6. Kirby RS. The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 2000; 56: 3-6.
7. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-479.
8. Carvalhal GF, Smith DS, Mager DE, Ramos C, Catalona WJ. Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng/ml or less. J Urol 1999; 161: 835-838.
9. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 1994; 151: 1283-1287.
10. Tombal B, de Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999; 84:1015-1020.
11. Nickel JC, Saad F. The American Urological Association 2003 Guideline on management of benign prostatic hyperplasia: a Canadian opinion. Can J Urol 2004; 11: 2186-2193.
12. Wasson JH, Reda DJ, Bruskewits RC, Elinson J, Keller AM, Henderson WG. Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995; 332: 75-79.
13. Drach GW, Layton TN, Binard WJ. Male peak urinary flow rate: relationships to volume voided and age. J Urol 1979; 122: 210-214.
14. Oesterling J. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate Suppl 1996; 6: 67-73.
15. Roehrborn CG. The epidemiology of acute urinary retention in benign prostatic hyperplasia. Rev Urol 2001; 3: 187-192.
16. Temml C, Brossner C, Schatzl G, Ponholzer A, Knoepp L, Madersbacher S, et al. The natural history of lower urinary tract symptoms over five years. Eur Urol 2003; 43: 374-380.
17. Wei JT, Schottenfeld D, Cooper K, Taylor JM, Faerber GJ, Velarde MA, et al. The natural history of lower urinary tract symptom in black American men. J Urol 2001; 165: 1521-1525.
18. Pan JH, Song P, Jin XY, Xiong EQ, Tang GZ. Uroflowmetric analysis of 1131 middle aged and elderly males. ACTA Academiae Medicinae Militaris Tertiae 2004; 26: 808-810.
19. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-2398.